The platinaboratrane [Pt(PPh 3 ){B(mt) 3 }] (Pt→B) 10 (mt = methimazolyl) is prone to oxidative addition reactions with a range of substrates (Cl 2, Br 2, I 2, HCl, CH 3 I) without disrupting the platinum−boron dative bond, as illustrated by the first structurally characterized platinaboratranes [PtH(PPh 3 ){B(mt) 3 }]Cl (Pt→B) 8 and [PtI 2 {B(mt) 3 }] (Pt→B) 8 .
No takes yet. Share an insight, caveat, or question.
Crossley et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: